Catalog Advanced Search

Search by Category
Search by Format
Search by Type
Sort By
Search by Favorites
Search by Keyword
Search by Category
Search by Format
Search by Type
Search by Speakers
Credits Offered
Search in Packages
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Favorites
Search by Keyword
Sort By

  • APSHO Membership Overview Webinar
    Contains 3 Component(s)

    A guide through your APSHO Member Benefits presented by Wendy H. Vogel, MSN, FNP, FAPO, Executive Director.

    This presentation will guide you through the many benefits available to APSHO members and show you how to leverage these resources to support your professional growth. From accessing exclusive content and networking opportunities to engaging with educational tools and career development resources—this is your chance to unlock the full value of your membership. Whether you're a new member or just want to brush up on member benefits, this is a great opportunity to explore all the tools and resources available to you.

    Wendy Vogel

    MSN, FNP, FAPO

    APSHO, Executive Director

    Wendy is a nationally recognized oncology nurse practitioner, founding Board Member and Executive Director of APSHO, and a tireless advocate for the role of the advanced practitioner in cancer care. She’s an award-winning educator, sought-after speaker, and driving force behind AP-focused education, collaboration, and innovation. Wendy brings contagious enthusiasm for all things oncology, advanced practice, and team-based care — inspiring clinicians to lead with knowledge, heart, and purpose.

    Ms. Vogel is a board-certified advanced oncology certified nurse practitioner and a certified family nurse practitioner. She is recognized as an APSHO distinguished Fellow of Advanced Practice in Oncology (FAPO).

    Wendy Vogel has no relevant financial relationships to disclose

  • Advanced Practitioner Leadership Course
    Contains 12 Product(s)

    The AP Leadership Course is an eleven‑module program that equips Advanced Practitioners with essential leadership, communication, and strategic management skills. Through practical tools and real‑world scenarios, participants build confidence, develop a personal leadership vision, and learn to drive meaningful impact across interdisciplinary teams and healthcare systems.

    1. Leadership Fundamentals
    2. Professionalism and Emotional Intelligence
    3. Effective Communication
    4. Developing Strategic Influencing Skills
    5. People Management
    6. Engagement and Succession Planning
    7. Business Results for AP Leaders
    8. Productivity and Maximizing AP Value
    9. Strategic Planning and Change Management
    10. Ethical Leadership and Cultural Humility
    11. Pharmacy Leadership Considerations

    © APSHO 2026. All Rights Reserved. The content, materials, and intellectual property presented on this course, including but not limited to text, graphics, images, designs, logos, videos, and code, are the exclusive property of APSHO, unless otherwise noted. Unauthorized reproduction, distribution, or use of any content without prior written permission is strictly prohibited. For inquiries about licensing or permissions, please contact APSHO directly at info@apsho.org.

  • Telehealth in Oncology: Opportunity for Improving Access and Outcomes
    Contains 3 Component(s)

    This session will provide an up‑to‑date overview of the statutes, regulations, and reimbursement policies shaping the delivery of telehealth services by oncology advanced practice providers (APs). Participants will explore practical use cases demonstrating how telehealth is being integrated into oncology care and examine common institutional, provider, and patient-level challenges that impact its effective utilization. Strategies to address these barriers will be discussed, along with a review of current research on telehealth-related patient outcomes in oncology. The session will conclude with a focused discussion on ways APSHO can further support APs in optimizing telehealth practices within oncology settings.

    • Regulatory & Policy Landscape
    • Telehealth Use Cases in Oncology
    • Challenges to Effective Telehealth Utilization
    • Telehealth and Patient Outcomes
    • Role of APSHO in Supporting AP Telehealth Utilization

    Genevieve Hollis (Moderator)

    MSN, CRNP, ANP-BC, AOCN

    Penn Medicine

    Genevieve Hollis began her oncology nursing career as a registered nurse in 1987. She has been in her current position as an oncology nurse practitioner at Penn Medicine in Philadelphia since 2007. Her clinical practice focuses on patients who have completed radiation therapy for GU malignancies who are now undergoing long term disease surveillance, symptom management, and survivorship. Approximately 50 % of these patient visits are completed via telemedicine. She is a member of Clinician Champion Telehealth Group at Penn Medicine.
    • Review status of statutes, regulations, and reimbursement policies that affect provision of telehealth for oncology services by APPs
    • Share use cases of telehealth in oncology
    • Discuss strategies to address institutional, provider, and patient challenges in the effective utilization of telehealth in oncology 
    • Summarize research findings related to telehealth patient outcomes
    • Explore measures that can be taken by APSHO to support oncology AP telehealth utilization

  • Top Radiation Oncology Conference Presentations of 2025
    Contains 3 Component(s)

    Tune to the APSHO Radiation Oncology APP Network featuring highlights from past conference presentations from 2025.

    Tune to the APSHO Radiation Oncology APP Network featuring highlights from past conference presentations from 2025.

    • Management of Radiation Side Effects–presented by Alexa Lantz, PA-C
    • Radiation Therapy for Benign Conditions–presented by Amanda Meyer, DNP, APRN
    • Multidisciplinary Management of Spinal Metastases: Integrating Surgery and Radiation Therapy–presented by Kate Martin, PA-C, MBA


    The content of this webinar is presented by APSHO but does not necessarily reflect the views, opinions, or ideas of APSHO as an organization. The content has not been peer-reviewed and is not eligible for continuing education credits. APSHO is not responsible for any medical decisions made by attendees based on the information provided in this presentation. Any issues, concerns, or questions regarding the presentation should be directed to info@apsho.org.  

    Management of Radiation Side Effects

    • Identify common acute and late radiation toxicities across major disease sites.
    • Apply evidence‑based prevention and management strategies for skin, CNS, GU, and head & neck side effects.
    • Recognize when advanced supportive measures (e.g., steroids, wound care, speech/swallow therapy) or diagnostic evaluation are needed.

    Radiation Therapy for Benign Conditions

    • Describe indications for low‑dose radiation in benign inflammatory and proliferative conditions.
    • Explain mechanisms of action (anti‑inflammatory and anti‑proliferative effects).
    • Evaluate risks, benefits, patient selection criteria, and expected outcomes.
    • Understand current evidence and emerging U.S. clinical trial activity.

    Multidisciplinary Management of Spinal Metastases

    • Explain basic spinal anatomy and associated symptomology.
    • Discuss radiographic sequences to assess spinal disease.
    • Identify indications necessitating surgical and radiation involvement.
    • Differentiate between palliative and stereotactic radiation approaches.

    Alexa Lantz, PA-C

    Penn State Health

    Alexa (Lexie) Lantz is a Physician Assistant in Radiation Oncology at Penn State Health in Hershey Pennsylvania where she has worked for the last 6 years and holds a faculty rank of Instructor. She has experience across all disease sites, but currently sees mostly CNS, GU, GYN, and Pediatric patients. In addition to her clinical role, she is part-time at the Penn State College of Medicine Physician Assistant Program.

    She will be presenting on the Management of Radiation Side Effects in today’s session.

    Alexa Lantz, PA-C has no relevant financial relationships to disclose.

    Amanda F. Meyer, DNP, APRN

    Mayo Clinic

    Amanda F. Meyer, DNP, APRN, is an Assistant Professor in the Department of Radiation Oncology and an Instructor in the Department of Family Medicine. She earned her Bachelor of Science in Nursing from South Dakota State University, her Master of Science in Nursing from Winona State University, and her Doctor of Nursing Practice from Viterbo University.

    Amanda serves as core faculty in the Doctor of Nursing Practice (DNP) program at Viterbo University. Her professional interests include tobacco cessation, advancement of APP research, and the use of low-dose radiation therapy for benign conditions.
    Outside of academia and clinical practice, she is a proud wife of a law enforcement officer and a devoted mother who can often be found chauffeuring her three sons to practices and games.

    She will be presenting on Radiation Therapy for Benign Conditions in today’s session.


    Amanda F. Meyer, DNP, APRN has no relevant financial relationships to disclose.

    Kate Martin

    PA-C, MBA

    Dana-Farber Brigham and Women's Cancer Center

    Kate Martin, PA-C, MBA, is the Director of APPs for Mass General Brigham (MGB) Department of Radiation Oncology and Director of APPs for the Department of Medical Oncology at Brigham and Women’s Hospital (BWH) in Boston.

    Kate began her career as a radiation therapist in 2007 at Roswell Park Cancer Institute in Buffalo, NY, before completing her Honours BSc in Neurobiology at Brock University and attending Weill Cornell Medical College where she obtained her Physician Assistant degree. She completed her MBA at Boston University’s Questrom School of Business.

    She started her career in inpatient medical oncology and neurosurgery. She ultimately joined the Department of Radiation Oncology in 2017 and rejoined the Department of Medical Oncology in 2025. Her primary clinical focus is adult and pediatric diseases of the central nervous system, both in the ambulatory and inpatient setting. Her administrative role focuses on oncology APP strategy, utilization of APPs in radiation and medical oncology, leadership development, and systems integration.

    Kate Martin, PA-C, MBA has no relevant financial relationships to disclose.

  • Theranostics - Cancer Treatment with Precision Medicine
    Contains 3 Component(s)

    Tune to the APSHO Radiation Oncology APP Network for a webinar on Theranostics - Cancer Treatment with Precision Medicine by Jamie Raney, MBA, CNMT

    Tune to the APSHO Radiation Oncology APP Network for a webinar on Theranostics - Cancer Treatment with Precision Medicine by Jamie Raney, MBA, CNMT

    • What is Theranostics? A high-level overview of Theranostics
    • Programs of Excellence: What good looks like
    • The Theranostics of Tomorrow: Innovations shaping the future
    • Impact of Theranostics in Radiation Therapy

    The content of this webinar is presented by APSHO but does not necessarily reflect the views, opinions, or ideas of APSHO as an organization. The content has not been peer-reviewed and is not eligible for continuing education credits. APSHO is not responsible for any medical decisions made by attendees based on the information provided in this presentation. Any issues, concerns, or questions regarding the presentation should be directed to info@apsho.org.  

    1. What is Theranostics? A High-Level Overview

    • Define the concept of theranostics and explain its role in cancer treatment.
    • Identify the key components and principles behind theranostic approaches.
    • Describe the clinical applications and benefits of theranostics in cancer care.

    2. Programs of Excellence: What Good Looks Like

    • Analyze the characteristics of successful theranostic programs.
    • Evaluate best practices for implementing theranostics in clinical settings.

    3. The Theranostics of Tomorrow: Innovations Shaping the Future

    • Explore emerging technologies and innovations driving theranostics forward.
    • Predict potential future applications and trends in theranostic research.
    • Assess the impact of AI, imaging, and molecular targeting on theranostics.

    4. Impact of Theranostics in Radiation Therapy

    • Explain how theranostics integrates with radiation therapy workflows.
    • Assess the clinical outcomes and patient benefits of theranostic-guided radiation therapy.
    • Discuss challenges and opportunities in combining theranostics with radiotherapy.

    Jamie Raney, MBA, CNMT

    Care Pathway Leader for Theranostics Strategy and Growth

    GE Healthcare

    Jamie Raney is a seasoned healthcare executive with over two decades of experience in nuclear medicine, theranostics, and imaging operations. Currently serving as the Care Pathway Leader for Theranostics Strategy and Growth at GE HealthCare, Jamie partners with providers across the U.S. and Canada to enable and optimize cutting-edge theranostics programs that elevate patient care and operational efficiency.

    Jamie's career spans leadership roles in both clinical and corporate settings, including as Regional Director of Operations at CDL Nuclear Technologies, Director of Imaging and Nuclear Medicine for Rocky Mountain Cancer Centers, and as Practice Administrator at BAMF Health, where he launched the clinical operations of a state-of-the-art Theranostics Center. His expertise also includes consulting for a national radiopharmacy network and serving as a Medical Science Liaison for Telix Pharmaceuticals, where he provided support in the pre-launch of illuccix as well as the research pipeline.

    With a strong foundation in nuclear medicine technology and a Master of Business Administration in Healthcare Management, Jamie brings a unique blend of clinical insight and strategic acumen. He is a Certified Nuclear Medicine Technologist and an active member of the Society of Nuclear Medicine and Molecular Imaging.

    Jamie is passionate about advancing theranostics and molecular imaging to improve outcomes for patients and communities. His leadership is marked by a commitment to operational excellence, innovation, and collaborative growth.

    Disclosure: Jamie Raney is the Theranostics Strategy & Growth Care Pathway Leader for the GE HealthCare overseeing United States and Canada.

  • Targets & Tactics: A Bispecific Master Class for the AP
    Contains 3 Product(s)

    This multi-session program provides advanced practitioners with a 360-degree view of BTCE therapy, spanning mechanisms of action, clinical trial evidence, patient selection, adverse event recognition and management, and practice implementation. The series blends evidence-based learning with case studies and multidisciplinary perspectives to prepare participants for leadership in BTCE adoption across diverse practice settings. Upon completion, learners will be able to safely and effectively apply BTCEs, improve patient and caregiver education, and contribute to system-level readiness for these novel therapies. Overall Program Learning Objectives: After completing this activity, learners will be able to: · Explain the mechanisms of action and approved indications of BTCEs. · Evaluate clinical data and guidelines supporting BTCE use. · Develop individualized patient treatment plans using BTCEs. · Recognize and manage common BTCE-related toxicities. · Integrate safety protocols into outpatient workflows. · Lead institutional and multidisciplinary efforts for BTCE adoption.

    Modules:

    Module 1: Clinical Application of Bispecific T-Cell Engagers

    Module 2: Bispecific T-Cell Engager Related Adverse Events

    Module 3: Implementing Bispecific T-Cell Engagers Into Practice: Mode

    © APSHO 2025. All Rights Reserved. The content, materials, and intellectual property presented on this course, including but not limited to text, graphics, images, designs, logos, videos, and code, are the exclusive property of APSHO, unless otherwise noted. Unauthorized reproduction, distribution, or use of any content without prior written permission is strictly prohibited. For inquiries about licensing or permissions, please contact APSHO directly at info@apsho.org.

  • Peer Review 101
    Contains 6 Component(s), Includes Credits
    Component Credit Type State/Medical Type Available Credits Earned Credits
    Peer Review 101 - CE Certificates Medical PA 1.00 0.00
    Peer Review 101 - CE Certificates Medical PharmD 1.00 0.00
    Peer Review 101 - CE Certificates Medical NP/Nursing 1.00 0.00
    Peer Review 101 - CE Certificates Medical Attendance (Other) 1.00 0.00

    This course empowers Advanced Practitioners to confidently conduct peer reviews of abstracts, posters, and manuscripts by applying IMRAD criteria, identifying bias, and structuring feedback effectively. Through case studies and practical tools, participants build skills in evaluating scientific quality, transparency, and methodological rigor. Ideal for APs involved in academic publishing, presentations, or mentoring.

    This comprehensive course equips APs with practical skills to confidently review abstracts, posters, and manuscripts

    1. Pre-test
    2. Introduction to peer reviewing
    3. Abstracts
    4. Posters
    5. Manuscripts
    6. Summary
    7. Post-test

    After the completion of this activity, the participant will be able to:

    • Identify the key components of written scholarly work, including abstracts, posters, and manuscripts
    • Describe sequence of steps required to evaluate scholarly work and provide a valuable peer review
    • Implement best practices in providing constructive feedback to submitting authors

    Antonia Corrigan, MSN, ANP-C, ACHPN

    Atrium Health Levine Cancer Institute

    Antonia Corrigan is the Chief APP for the Department of Supportive Oncology at the Levine Cancer Institute in Charlotte, North Carolina. Throughout her 21-year career, her focus has been oncology and palliative medicine. She has presented nationally and regionally and has designed and participated in multiple institution- based educational activities focusing on the varied aspects of symptom management in the oncology setting.

    Antonia Corrigan has no relevant financial relationships to disclose.

  • APSHO Advanced Practitioner Onboarding Course
    Contains 16 Product(s)

    The Advanced Practitioner Onboarding Course is a 20-hour program designed to prepare Advanced Practitioners (APs) for delivering high-quality, evidence-based oncology care. It covers the full cancer care continuum—from foundational science and diagnostics to treatment, survivorship, and end-of-life care. The course also emphasizes professional development, including clinical research, documentation, and personal well-being. By the end, participants will be equipped to apply evidence-based guidelines, create individualized care plans, contribute to research, and sustain resilience in oncology practice.

    The following topics will be covered in this course:

    1. Introduction to Oncology
    2. Oncogenesis
    3. Cancer Screenings, Diagnostics, and Staging
    4. Lab Testing Breakdown
    5. Patient Evaluation and Simulation
    6. Treatment Modalities
    7. Management of Common Acute Conditions
    8. Psychosocial and Supportive Care
    9. Adolescents and Young Adults (AYA) with Cancer
    10. Health Maintenance and Survivorship
    11. Palliative Care and Hospice
    12. The AP’s Role in Research
    13. Clinical Documentation and EMR Best Practices
    14. AP Practice Fundamentals and Professional Development
    15. Physical and Mental Health of the AP

    © APSHO 2025. All Rights Reserved. The content, materials, and intellectual property presented on this course, including but not limited to text, graphics, images, designs, logos, videos, and code, are the exclusive property of APSHO, unless otherwise noted. Unauthorized reproduction, distribution, or use of any content without prior written permission is strictly prohibited. For inquiries about licensing or permissions, please contact APSHO directly at info@apsho.org.

  • Genomics 101 for APs
    Contains 8 Component(s)

    This introductory course offers advanced practitioners a foundational understanding of genomics in oncology. Participants will explore how genetic alterations contribute to cancer development, learn about key biomarker testing methods, and understand the role of genomic profiling in guiding targeted therapy and monitoring treatment resistance

    This introductory course offers advanced practitioners a foundational understanding of genomics in oncology. Participants will explore how genetic alterations contribute to cancer development, learn about key biomarker testing methods, and understand the role of genomic profiling in guiding targeted therapy and monitoring treatment resistance.


    Outline:

    •Introduction

    •Cancer: a disease of the genome

    •Biomarker testing

    •Next generation sequencing (NGS)

    •Clinical application

    Candice Graham-Adderton DNP, MPH, FNP-C, CHES

    Guardant Health

    Candice is a family nurse practitioner with over a decade of experience in health care. At Guardant Health, she leverages her clinical and public health expertise to support the use of genomic testing in cancer care. She also co-leads the Guardant Health Advanced Practitioner Education Committee, helping to strengthen education and engagement among oncology advanced practitioners.

    Cristin O’Neal MSN, ANP-C

    Guardant Health

    Cristin O'Neal MSN, ANP-c is an advanced practitioner with 18 years of oncology experience, including 7 years as a nurse practitioner in oncology. She is currently part of the Medical Affairs team at Guardant Health, where she provides molecular education to oncology practices nationwide. Cristin also co-leads the Guardant Health Advanced Practitioner (AP) Education Committee, which supports external training and development for APs in oncology.

    Disclaimer: The content of this webinar is presented by APSHO but does not necessarily reflect the views, opinions, or ideas of APSHO as an organization. The content has not been peer-reviewed and is not eligible for continuing education credits. APSHO is not responsible for any medical decisions made by attendees based on the information provided in this presentation. Any issues, concerns, or questions regarding the presentation should be directed to info@apsho.org.  

  • Driving Sustainable Change in Clinical Research
    Contains 3 Component(s)

    Learn how advanced practitioners (APs) can lead lasting improvements in clinical research programs through innovative tools and strategies that align with institutional goals. This webinar will also delve into how AP-driven trial counseling enhances patient access, promotes equity, and strengthens the foundation for sustainable research.

    Tune to the APSHO Research and Quality Improvement Forum for a webinar on Driving Sustainable Change in Clinical Research with Rochelle Reyes, PA-C. In this session you will:

    ● Learn how APs lead enduring improvements in clinical research practices.
    ● Understand how AP strategies align with institutional goals for maximum impact.
    ● See how AP-developed clinical tools enable sustainable change.
    ● Recognize how trial counseling by APs increases patient access to trials and promotes health equity.


    The content of this webinar is presented by APSHO but does not necessarily reflect the views, opinions, or ideas of APSHO as an organization. The content has not been peer-reviewed and is not eligible for continuing education credits. APSHO is not responsible for any medical decisions made by attendees based on the information provided in this presentation. Any issues, concerns, or questions regarding the presentation should be directed to info@apsho.org.  

    Every health-care provider should make their own determination regarding specific safe and appropriate patient care practices, including dosages and indications, considering patient-specific characteristics, institutional policies and procedures, personnel, and equipment. The provider should always consult the most recent prescribing/product information. 

    Rochelle Reyes, PA-C

    Mayo Clinic

    Rochelle went to George Washington University, followed by PA Studies at Stony Brook University in New York. She is currently a Physician Assistant in the Early Cancer Therapeutics Program at Mayo Clinic Rochester in Minnesota.  She previously worked at Stanford Medicine in Palo Alto California in various NPPA med onc roles, but exclusively in Clinical Research since 2016. She has had the very good fortune of working with physicians and CRCs that were committed to a patient-first vision for their research program, and promotion of health equity in research.  

    When she's not working, she's planning the family's next surf trip.  She loves spending time outdoors with her husband and 5yo son. She doesn't love cleaning up after their 18mo doodle puppy.

    Speaker Disclosure: No relevant financial relationships to disclose.